
Zura Bio Ltd — Investor Relations & Filings
Zura Bio Ltd. is a multi-asset, clinical-stage biotechnology company focused on developing novel medicines for severe autoimmune and inflammatory disorders. The company's strategy centers on dual-pathway biology, aiming to create transformative solutions for patients whose needs are not adequately met by single-pathway medicines. Its development portfolio includes the therapeutic candidates tibulizumab (ZB-106), crebankitug (ZB-168), and torudokimab (ZB-880). Zura Bio's mission is to enhance patient well-being by developing innovative dual-pathway antibody therapies that demonstrate efficacy, safety, and dosing convenience for challenging immunological conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEFA14A | 2026-05-22 | English | |
| FORM 8-K | 2026-05-22 | English | |
| 8-K - Zura Bio Ltd (0001855644) (Filer) | 2026-05-07 | English | |
| 10-Q - Zura Bio Ltd (0001855644) (Filer) | 2026-05-07 | English | |
| ARS - Zura Bio Ltd (0001855644) (Filer) | 2026-04-30 | English | |
| 8-K - Zura Bio Ltd (0001855644) (Filer) | 2026-04-23 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46859662 | DEFA14A | 2026-05-22 | English | ||
| 46858918 | FORM 8-K | 2026-05-22 | English | ||
| 42867675 | 8-K - Zura Bio Ltd (0001855644) (Filer) | 2026-05-07 | English | ||
| 42860160 | 10-Q - Zura Bio Ltd (0001855644) (Filer) | 2026-05-07 | English | ||
| 39212811 | ARS - Zura Bio Ltd (0001855644) (Filer) | 2026-04-30 | English | ||
| 35883008 | 8-K - Zura Bio Ltd (0001855644) (Filer) | 2026-04-23 | English | ||
| 32899881 | 4 - ZURA BIO LTD (0001855644) (Filer) | 2026-03-02 | English | ||
| 32899884 | 8-K - ZURA BIO LTD (0001855644) (Filer) | 2026-02-26 | English | ||
| 32899882 | 4 - ZURA BIO LTD (0001855644) (Filer) | 2026-02-25 | English | ||
| 32899883 | 8-K - ZURA BIO LTD (0001855644) (Filer) | 2026-02-23 | English | ||
| 32089141 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32089282 | 8-K Filing | 2026-02-11 | English | ||
| 32089078 | 3 Filing | 2026-01-27 | English | ||
| 32088995 | SCHEDULE 13D Filing | 2026-01-27 | English | ||
| 32088979 | 4 Filing | 2026-01-27 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Zura Bio Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33996/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33996 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33996 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33996 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33996}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Zura Bio Ltd (id: 33996)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.